The Role of TGF-Beta in Acute Lung Injury
TGF-β 在急性肺损伤中的作用
基本信息
- 批准号:6552553
- 负责人:
- 金额:$ 4.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-20 至
- 项目状态:未结题
- 来源:
- 关键词:biological signal transduction bleomycin cytokine epithelium flow cytometry fluorescence microscopy glutathione histochemistry /cytochemistry intercellular connection laboratory mouse lipopolysaccharides lung injury northern blottings phosphorylation postdoctoral investigator protein structure function pulmonary edema receptor expression tissue /cell culture transforming growth factors western blottings
项目摘要
DESCRIPTION (provided by applicant): We wish to identify molecular mechanisms leading to the development of acute lung injury (ALI). This devastating clinical syndrome is characterized by formation of pulmonary edema--alveolar flooding with a protein-rich exudate. Recently, our laboratory has identified the cytokine transforming growth factor-Beta (TGF-Beta) as a possible critical mediator in ALI; inhibition of TGF-Beta prevents the development of pulmonary edema in murine models. Other investigators have shown that TGF-Beta directly increases endothelial permeability in vitro. We have found that TGF-Beta directly increases epithelial permeability by a mechanism that is associated with depletion of intracellular glutathione (GSH). We hypothesize that locally activated TGF-Beta mediates the development of pulmonary edema associated with ALI by exerting specific effects on resident epithelial and endothelial cells. Furthermore, we hypothesize that TGF-Beta alters the phosphorylation state of endothelial and epithelial cell junction proteins by mechanisms involving changes in intracellular thiol redox status. Junction protein phosphorylation would affect junction integrity, and therefore, the degree of paracellular permeability. We will use TGF-Beta green fluorescent protein reporter mice to identify individual resident epithelial and endothelial cells that are stimulated by TGF-Beta in vivo. Epithelial and endothelial cell monolayers will be used to assess TGF-Beta effect on paracellular permeability. Reduced and oxidized GSH will be measured to determine thiol redox status. Epithelial and endothelial junction protein phosphorylation state will be determined and specific proteins identified. In contrast to most other potential treatments for ALT, which are effective only if administered before the onset of injury, TGF-Beta inhibition effectively attenuates ALT even after the onset of injury (previously shown in our laboratory). Therefore, identification of specific molecular mechanisms by which TGF-Beta affects epithelial and/or endothelial cells could lead to novel and improved strategies to treat ALI, a common and often lethal clinical syndrome. The proposed studies will also help me develop and acquire the necessary skills to achieve my ultimate goal of becoming a successful and independent scientist in pulmonary disease.
描述(申请人提供):我们希望确定导致急性肺损伤(ALI)发生的分子机制。这种破坏性的临床综合征的特征是形成肺水肿--肺泡内充满富含蛋白质的渗出物。最近,我们实验室已确定细胞因子转化生长因子-β(TGF-β)可能是ALI的关键介质;抑制转化生长因子-β可阻止小鼠肺水肿的发展。其他研究人员已经表明,转化生长因子-β在体外直接增加内皮细胞的通透性。我们已经发现,转化生长因子-β通过一种与细胞内谷胱甘肽(GSH)耗竭有关的机制直接增加上皮的通透性。我们推测局部激活的转化生长因子-β通过对肺泡内皮细胞和内皮细胞的特异性作用而介导了与ALI相关的肺水肿的发展。此外,我们假设转化生长因子-β通过改变细胞内硫醇氧化还原状态来改变内皮细胞和上皮细胞连接蛋白的磷酸化状态。连接蛋白的磷酸化会影响连接的完整性,从而影响细胞旁通透性的程度。我们将使用转化生长因子-β绿色荧光蛋白报告鼠在体内识别转化生长因子-β刺激的单个常驻上皮细胞和内皮细胞。上皮细胞和内皮细胞单层将被用来评估转化生长因子-β对细胞旁通透性的影响。将测定还原型和氧化型谷胱甘肽,以确定硫醇氧化还原状态。将测定上皮和内皮连接蛋白的磷酸化状态,并鉴定特定蛋白。与大多数其他潜在的治疗ALT的方法不同,只有在损伤开始之前才能有效地使用转化生长因子-β抑制,即使在损伤开始后也能有效地降低ALT(以前在我们的实验室中显示)。因此,识别转化生长因子-β影响上皮和/或内皮细胞的特定分子机制可能导致治疗ALI的新的和改进的策略,ALI是一种常见的临床综合征,通常是致命的。拟议的研究还将帮助我发展和获得必要的技能,以实现我成为一名成功和独立的肺部疾病科学家的最终目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE SU其他文献
GEORGE SU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE SU', 18)}}的其他基金
Pulmonary Specialist-Health Coach Consult (PuSHCon) model to improve access to specialist consultation and receipt of recommended evidence-based care for vulnerable patients with COPD and asthma
肺科专家健康教练咨询 (PuSHCon) 模式旨在改善慢性阻塞性肺病和哮喘患者获得专家咨询的机会并获得推荐的循证护理
- 批准号:
10215610 - 财政年份:2019
- 资助金额:
$ 4.21万 - 项目类别:
Pulmonary Specialist-Health Coach Consult (PuSHCon) model to improve access to specialist consultation and receipt of recommended evidence-based care for vulnerable patients with COPD and asthma
肺科专家健康教练咨询 (PuSHCon) 模式旨在改善慢性阻塞性肺病和哮喘患者获得专家咨询的机会并获得推荐的循证护理
- 批准号:
10004714 - 财政年份:2019
- 资助金额:
$ 4.21万 - 项目类别:
Pulmonary Specialist-Health Coach Consult (PuSHCon) model to improve access to specialist consultation and receipt of recommended evidence-based care for vulnerable patients with COPD and asthma
肺科专家健康教练咨询 (PuSHCon) 模式旨在改善慢性阻塞性肺病和哮喘患者获得专家咨询的机会并获得推荐的循证护理
- 批准号:
10451757 - 财政年份:2019
- 资助金额:
$ 4.21万 - 项目类别:
The Role of Integrins AlphaVBeta3 and AlphaVBeta5 in Acute Lung Injury
整合素 AlphaVBeta3 和 AlphaVBeta5 在急性肺损伤中的作用
- 批准号:
7315627 - 财政年份:2007
- 资助金额:
$ 4.21万 - 项目类别:
The Role of Integrins AlphaVBeta3 and AlphaVBeta5 in Acute Lung Injury
整合素 AlphaVBeta3 和 AlphaVBeta5 在急性肺损伤中的作用
- 批准号:
8099485 - 财政年份:2007
- 资助金额:
$ 4.21万 - 项目类别:
The Role of Integrins AlphaVBeta3 and AlphaVBeta5 in Acute Lung Injury
整合素 AlphaVBeta3 和 AlphaVBeta5 在急性肺损伤中的作用
- 批准号:
7645535 - 财政年份:2007
- 资助金额:
$ 4.21万 - 项目类别:
The Role of Integrins AlphaVBeta3 and AlphaVBeta5 in Acute Lung Injury
整合素 AlphaVBeta3 和 AlphaVBeta5 在急性肺损伤中的作用
- 批准号:
7471369 - 财政年份:2007
- 资助金额:
$ 4.21万 - 项目类别:
The Role of Integrins AlphaVBeta3 and AlphaVBeta5 in Acute Lung Injury
整合素 AlphaVBeta3 和 AlphaVBeta5 在急性肺损伤中的作用
- 批准号:
7880778 - 财政年份:2007
- 资助金额:
$ 4.21万 - 项目类别:
相似海外基金
Epalrestat, an aldose reductase inhibitor, alleviates bleomycin-induced skin fibrosis in mice : drug repositioning study for human systemic sclerosis
依帕司他(一种醛糖还原酶抑制剂)可减轻博来霉素诱导的小鼠皮肤纤维化:人类系统性硬化症的药物重新定位研究
- 批准号:
20K17346 - 财政年份:2020
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapy for melanoma with the combination of bleomycin and immune checkpoint inhibitors
博来霉素和免疫检查点抑制剂联合治疗黑色素瘤
- 批准号:
19K08760 - 财政年份:2019
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Thrombomodulin suppresses bleomycin-induced pulmonary fibrosis and develop to a new candidate for IPF treatment
血栓调节蛋白可抑制博莱霉素诱导的肺纤维化,成为 IPF 治疗的新候选药物
- 批准号:
19K08844 - 财政年份:2019
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A role of FcgRIIB in the development of murine bleomycin-induced fibrosis model
FcgRIIB 在小鼠博莱霉素诱导的纤维化模型发展中的作用
- 批准号:
19K17766 - 财政年份:2019
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis
血管内皮生长因子受体1酪氨酸激酶信号在博莱霉素诱导的肺纤维化中的作用
- 批准号:
19K09291 - 财政年份:2019
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of alveolar epithelial type I cells in bleomycin-induced lung injury: Characterization of fibrosis-relevant signal pathways
I 型肺泡上皮细胞在博来霉素诱导的肺损伤中的作用:纤维化相关信号通路的表征
- 批准号:
373703964 - 财政年份:2017
- 资助金额:
$ 4.21万 - 项目类别:
Research Grants
Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced scleroderma
静脉脂肪干细胞移植对博来霉素诱导的硬皮病小鼠模型的抗炎和抗纤维化作用
- 批准号:
17K16216 - 财政年份:2017
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Changes in pulmonary endothelial cell and fibroblast properties during bleomycin-induced pulmonary fibrosis
博来霉素诱导肺纤维化过程中肺内皮细胞和成纤维细胞特性的变化
- 批准号:
17K09609 - 财政年份:2017
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Statin-polymer nanoparticles enhance the anti-inflammatory and anti-fibrotic effects of adipose-derived stem cell transplantation in a mouse model of bleomycin-induced scleroderma
他汀类聚合物纳米粒子增强博莱霉素诱导的硬皮病小鼠模型中脂肪干细胞移植的抗炎和抗纤维化作用
- 批准号:
17K15761 - 财政年份:2017
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Effect of function-blocking RHAMM peptides on adipogenesis in a bleomycin-induced scleroderma mouse model
功能阻断 RHAMM 肽对博莱霉素诱导的硬皮病小鼠模型脂肪生成的影响
- 批准号:
367375 - 财政年份:2016
- 资助金额:
$ 4.21万 - 项目类别:
Studentship Programs